Sleep movement disorders are the disorders disrupting during sleep and generally have undesirable verbal or physical behaviors which frequently result in insomnia and daytime fatigue. Movements during sleep are very common, especially among children.

Market Analysis and Insights: Global Sleep Movement Disorder Drug Market

The global Sleep Movement Disorder Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Sleep Movement Disorder Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sleep Movement Disorder Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sleep Movement Disorder Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sleep Movement Disorder Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sleep Movement Disorder Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sleep Movement Disorder Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Sleep Movement Disorder Drug Market Report

Report Metric	Details
Report Name	Sleep Movement Disorder Drug Market
CAGR	5%
Segment by Type	Benzodiazepines Opioids Anticonvulsants Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cardinal Health, Mylan, Teva, Shermco, Vollin Holdings, Allergan, Pfizer, GlaxoSmithKline, BD
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sleep Movement Disorder Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep Movement Disorder Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sleep Movement Disorder Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Sleep Movement Disorder Drug Market report?

Ans: The main players in the Sleep Movement Disorder Drug Market are Cardinal Health, Mylan, Teva, Shermco, Vollin Holdings, Allergan, Pfizer, GlaxoSmithKline, BD

What are the Application segmentation covered in the Sleep Movement Disorder Drug Market report?

Ans: The Applications covered in the Sleep Movement Disorder Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Sleep Movement Disorder Drug Market report?

Ans: The Types covered in the Sleep Movement Disorder Drug Market report are Benzodiazepines, Opioids, Anticonvulsants, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sleep Movement Disorder Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Benzodiazepines

1.2.3 Opioids

1.2.4 Anticonvulsants

1.2.5 Others

1.3 Market by Application

1.3.1 Global Sleep Movement Disorder Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sleep Movement Disorder Drug Market Perspective (2019-2030)

2.2 Global Sleep Movement Disorder Drug Growth Trends by Region

2.2.1 Sleep Movement Disorder Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Sleep Movement Disorder Drug Historic Market Size by Region (2019-2024)

2.2.3 Sleep Movement Disorder Drug Forecasted Market Size by Region (2025-2030)

2.3 Sleep Movement Disorder Drug Market Dynamics

2.3.1 Sleep Movement Disorder Drug Industry Trends

2.3.2 Sleep Movement Disorder Drug Market Drivers

2.3.3 Sleep Movement Disorder Drug Market Challenges

2.3.4 Sleep Movement Disorder Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Sleep Movement Disorder Drug by Players

3.1.1 Global Sleep Movement Disorder Drug Revenue by Players (2019-2024)

3.1.2 Global Sleep Movement Disorder Drug Revenue Market Share by Players (2019-2024)

3.2 Global Sleep Movement Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Sleep Movement Disorder Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Sleep Movement Disorder Drug Market Concentration Ratio

3.4.1 Global Sleep Movement Disorder Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sleep Movement Disorder Drug Revenue in 2023

3.5 Global Key Players of Sleep Movement Disorder Drug Head office and Area Served

3.6 Global Key Players of Sleep Movement Disorder Drug, Product and Application

3.7 Global Key Players of Sleep Movement Disorder Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sleep Movement Disorder Drug Breakdown Data by Type

4.1 Global Sleep Movement Disorder Drug Historic Market Size by Type (2019-2024)

4.2 Global Sleep Movement Disorder Drug Forecasted Market Size by Type (2025-2030)

5 Sleep Movement Disorder Drug Breakdown Data by Application

5.1 Global Sleep Movement Disorder Drug Historic Market Size by Application (2019-2024)

5.2 Global Sleep Movement Disorder Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Sleep Movement Disorder Drug Market Size (2019-2030)

6.2 North America Sleep Movement Disorder Drug Market Size by Type

6.2.1 North America Sleep Movement Disorder Drug Market Size by Type (2019-2024)

6.2.2 North America Sleep Movement Disorder Drug Market Size by Type (2025-2030)

6.2.3 North America Sleep Movement Disorder Drug Market Share by Type (2019-2030)

6.3 North America Sleep Movement Disorder Drug Market Size by Application

6.3.1 North America Sleep Movement Disorder Drug Market Size by Application (2019-2024)

6.3.2 North America Sleep Movement Disorder Drug Market Size by Application (2025-2030)

6.3.3 North America Sleep Movement Disorder Drug Market Share by Application (2019-2030)

6.4 North America Sleep Movement Disorder Drug Market Size by Country

6.4.1 North America Sleep Movement Disorder Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Sleep Movement Disorder Drug Market Size by Country (2019-2024)

6.4.3 North America Sleep Movement Disorder Drug Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Sleep Movement Disorder Drug Market Size (2019-2030)

7.2 Europe Sleep Movement Disorder Drug Market Size by Type

7.2.1 Europe Sleep Movement Disorder Drug Market Size by Type (2019-2024)

7.2.2 Europe Sleep Movement Disorder Drug Market Size by Type (2025-2030)

7.2.3 Europe Sleep Movement Disorder Drug Market Share by Type (2019-2030)

7.3 Europe Sleep Movement Disorder Drug Market Size by Application

7.3.1 Europe Sleep Movement Disorder Drug Market Size by Application (2019-2024)

7.3.2 Europe Sleep Movement Disorder Drug Market Size by Application (2025-2030)

7.3.3 Europe Sleep Movement Disorder Drug Market Share by Application (2019-2030)

7.4 Europe Sleep Movement Disorder Drug Market Size by Country

7.4.1 Europe Sleep Movement Disorder Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Sleep Movement Disorder Drug Market Size by Country (2019-2024)

7.4.3 Europe Sleep Movement Disorder Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Sleep Movement Disorder Drug Market Size (2019-2030)

8.2 China Sleep Movement Disorder Drug Market Size by Type

8.2.1 China Sleep Movement Disorder Drug Market Size by Type (2019-2024)

8.2.2 China Sleep Movement Disorder Drug Market Size by Type (2025-2030)

8.2.3 China Sleep Movement Disorder Drug Market Share by Type (2019-2030)

8.3 China Sleep Movement Disorder Drug Market Size by Application

8.3.1 China Sleep Movement Disorder Drug Market Size by Application (2019-2024)

8.3.2 China Sleep Movement Disorder Drug Market Size by Application (2025-2030)

8.3.3 China Sleep Movement Disorder Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Sleep Movement Disorder Drug Market Size (2019-2030)

9.2 Asia Sleep Movement Disorder Drug Market Size by Type

9.2.1 Asia Sleep Movement Disorder Drug Market Size by Type (2019-2024)

9.2.2 Asia Sleep Movement Disorder Drug Market Size by Type (2025-2030)

9.2.3 Asia Sleep Movement Disorder Drug Market Share by Type (2019-2030)

9.3 Asia Sleep Movement Disorder Drug Market Size by Application

9.3.1 Asia Sleep Movement Disorder Drug Market Size by Application (2019-2024)

9.3.2 Asia Sleep Movement Disorder Drug Market Size by Application (2025-2030)

9.3.3 Asia Sleep Movement Disorder Drug Market Share by Application (2019-2030)

9.4 Asia Sleep Movement Disorder Drug Market Size by Region

9.4.1 Asia Sleep Movement Disorder Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Sleep Movement Disorder Drug Market Size by Region (2019-2024)

9.4.3 Asia Sleep Movement Disorder Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Cardinal Health

11.1.1 Cardinal Health Company Details

11.1.2 Cardinal Health Business Overview

11.1.3 Cardinal Health Sleep Movement Disorder Drug Introduction

11.1.4 Cardinal Health Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.1.5 Cardinal Health Recent Developments

11.2 Mylan

11.2.1 Mylan Company Details

11.2.2 Mylan Business Overview

11.2.3 Mylan Sleep Movement Disorder Drug Introduction

11.2.4 Mylan Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.2.5 Mylan Recent Developments

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva Sleep Movement Disorder Drug Introduction

11.3.4 Teva Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.3.5 Teva Recent Developments

11.4 Shermco

11.4.1 Shermco Company Details

11.4.2 Shermco Business Overview

11.4.3 Shermco Sleep Movement Disorder Drug Introduction

11.4.4 Shermco Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.4.5 Shermco Recent Developments

11.5 Vollin Holdings

11.5.1 Vollin Holdings Company Details

11.5.2 Vollin Holdings Business Overview

11.5.3 Vollin Holdings Sleep Movement Disorder Drug Introduction

11.5.4 Vollin Holdings Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.5.5 Vollin Holdings Recent Developments

11.6 Allergan

11.6.1 Allergan Company Details

11.6.2 Allergan Business Overview

11.6.3 Allergan Sleep Movement Disorder Drug Introduction

11.6.4 Allergan Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.6.5 Allergan Recent Developments

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Sleep Movement Disorder Drug Introduction

11.7.4 Pfizer Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.7.5 Pfizer Recent Developments

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Details

11.8.2 GlaxoSmithKline Business Overview

11.8.3 GlaxoSmithKline Sleep Movement Disorder Drug Introduction

11.8.4 GlaxoSmithKline Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.8.5 GlaxoSmithKline Recent Developments

11.9 BD

11.9.1 BD Company Details

11.9.2 BD Business Overview

11.9.3 BD Sleep Movement Disorder Drug Introduction

11.9.4 BD Revenue in Sleep Movement Disorder Drug Business (2019-2024)

11.9.5 BD Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Sleep Movement Disorder Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Benzodiazepines

Table 3. Key Players of Opioids

Table 4. Key Players of Anticonvulsants

Table 5. Key Players of Others

Table 6. Global Sleep Movement Disorder Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Sleep Movement Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Sleep Movement Disorder Drug Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Sleep Movement Disorder Drug Market Share by Region (2019-2024)

Table 10. Global Sleep Movement Disorder Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Sleep Movement Disorder Drug Market Share by Region (2025-2030)

Table 12. Sleep Movement Disorder Drug Market Trends

Table 13. Sleep Movement Disorder Drug Market Drivers

Table 14. Sleep Movement Disorder Drug Market Challenges

Table 15. Sleep Movement Disorder Drug Market Restraints

Table 16. Global Sleep Movement Disorder Drug Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Sleep Movement Disorder Drug Revenue Share by Players (2019-2024)

Table 18. Global Top Sleep Movement Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Movement Disorder Drug as of 2023)

Table 19. Global Sleep Movement Disorder Drug Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Sleep Movement Disorder Drug Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Sleep Movement Disorder Drug, Headquarters and Area Served

Table 22. Global Key Players of Sleep Movement Disorder Drug, Product and Application

Table 23. Global Key Players of Sleep Movement Disorder Drug, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Sleep Movement Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Sleep Movement Disorder Drug Revenue Market Share by Type (2019-2024)

Table 27. Global Sleep Movement Disorder Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Sleep Movement Disorder Drug Revenue Market Share by Type (2025-2030)

Table 29. Global Sleep Movement Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Sleep Movement Disorder Drug Revenue Share by Application (2019-2024)

Table 31. Global Sleep Movement Disorder Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Sleep Movement Disorder Drug Revenue Share by Application (2025-2030)

Table 33. North America Sleep Movement Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Sleep Movement Disorder Drug Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Sleep Movement Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Sleep Movement Disorder Drug Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Sleep Movement Disorder Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Sleep Movement Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Sleep Movement Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Sleep Movement Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Sleep Movement Disorder Drug Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Sleep Movement Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Sleep Movement Disorder Drug Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Sleep Movement Disorder Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Sleep Movement Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Sleep Movement Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Sleep Movement Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Sleep Movement Disorder Drug Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Sleep Movement Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Sleep Movement Disorder Drug Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Sleep Movement Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Sleep Movement Disorder Drug Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Sleep Movement Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Sleep Movement Disorder Drug Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Sleep Movement Disorder Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Sleep Movement Disorder Drug Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Sleep Movement Disorder Drug Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 65. Cardinal Health Company Details

Table 66. Cardinal Health Business Overview

Table 67. Cardinal Health Sleep Movement Disorder Drug Product

Table 68. Cardinal Health Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 69. Cardinal Health Recent Developments

Table 70. Mylan Company Details

Table 71. Mylan Business Overview

Table 72. Mylan Sleep Movement Disorder Drug Product

Table 73. Mylan Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 74. Mylan Recent Developments

Table 75. Teva Company Details

Table 76. Teva Business Overview

Table 77. Teva Sleep Movement Disorder Drug Product

Table 78. Teva Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 79. Teva Recent Developments

Table 80. Shermco Company Details

Table 81. Shermco Business Overview

Table 82. Shermco Sleep Movement Disorder Drug Product

Table 83. Shermco Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 84. Shermco Recent Developments

Table 85. Vollin Holdings Company Details

Table 86. Vollin Holdings Business Overview

Table 87. Vollin Holdings Sleep Movement Disorder Drug Product

Table 88. Vollin Holdings Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 89. Vollin Holdings Recent Developments

Table 90. Allergan Company Details

Table 91. Allergan Business Overview

Table 92. Allergan Sleep Movement Disorder Drug Product

Table 93. Allergan Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 94. Allergan Recent Developments

Table 95. Pfizer Company Details

Table 96. Pfizer Business Overview

Table 97. Pfizer Sleep Movement Disorder Drug Product

Table 98. Pfizer Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 99. Pfizer Recent Developments

Table 100. GlaxoSmithKline Company Details

Table 101. GlaxoSmithKline Business Overview

Table 102. GlaxoSmithKline Sleep Movement Disorder Drug Product

Table 103. GlaxoSmithKline Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 104. GlaxoSmithKline Recent Developments

Table 105. BD Company Details

Table 106. BD Business Overview

Table 107. BD Sleep Movement Disorder Drug Product

Table 108. BD Revenue in Sleep Movement Disorder Drug Business (2019-2024) & (US$ Million)

Table 109. BD Recent Developments

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Sleep Movement Disorder Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Sleep Movement Disorder Drug Market Share by Type: 2023 VS 2030

Figure 3. Benzodiazepines Features

Figure 4. Opioids Features

Figure 5. Anticonvulsants Features

Figure 6. Others Features

Figure 7. Global Sleep Movement Disorder Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Sleep Movement Disorder Drug Market Share by Application: 2023 VS 2030

Figure 9. Hospital Pharmacies Case Studies

Figure 10. Retail Pharmacies Case Studies

Figure 11. Online Pharmacies Case Studies

Figure 12. Sleep Movement Disorder Drug Report Years Considered

Figure 13. Global Sleep Movement Disorder Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Sleep Movement Disorder Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Sleep Movement Disorder Drug Market Share by Region: 2023 VS 2030

Figure 16. Global Sleep Movement Disorder Drug Market Share by Players in 2023

Figure 17. Global Top Sleep Movement Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Movement Disorder Drug as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Sleep Movement Disorder Drug Revenue in 2023

Figure 19. North America Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Sleep Movement Disorder Drug Market Share by Type (2019-2030)

Figure 21. North America Sleep Movement Disorder Drug Market Share by Application (2019-2030)

Figure 22. North America Sleep Movement Disorder Drug Market Share by Country (2019-2030)

Figure 23. United States Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Sleep Movement Disorder Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Sleep Movement Disorder Drug Market Share by Type (2019-2030)

Figure 27. Europe Sleep Movement Disorder Drug Market Share by Application (2019-2030)

Figure 28. Europe Sleep Movement Disorder Drug Market Share by Country (2019-2030)

Figure 29. Germany Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Sleep Movement Disorder Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Sleep Movement Disorder Drug Market Share by Type (2019-2030)

Figure 37. China Sleep Movement Disorder Drug Market Share by Application (2019-2030)

Figure 38. Asia Sleep Movement Disorder Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Sleep Movement Disorder Drug Market Share by Type (2019-2030)

Figure 40. Asia Sleep Movement Disorder Drug Market Share by Application (2019-2030)

Figure 41. Asia Sleep Movement Disorder Drug Market Share by Region (2019-2030)

Figure 42. Japan Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Sleep Movement Disorder Drug Market Share by Country (2019-2030)

Figure 52. Brazil Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Sleep Movement Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Cardinal Health Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 59. Mylan Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 60. Teva Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 61. Shermco Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 62. Vollin Holdings Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 63. Allergan Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 64. Pfizer Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 65. GlaxoSmithKline Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 66. BD Revenue Growth Rate in Sleep Movement Disorder Drug Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Insomnia Treatment Drugs Market Insights Forecast to 2030

Global Sleep Disorder Therapies Market Research Report 2024

Sleep Wake Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sleep Disorder Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypersomnia Drug Market Insights Forecast to 2030

Global Sleep Apnea Therapies Market Insights Forecast to 2030

Global Circadian Rhythm Sleep Disorders Drug Market Research Report 2025

Global Obsessive Compulsive Disorder Drugs Market Insights Forecast to 2030

Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030

Global Dystonia Drugs Market Research Report 2025

Tardive Dyskinesia Treatment Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiometabolic Drug Market Insights Forecast to 2030

Global Anti snoring Treatment Market Insights Forecast to 2030

Global Blood Pressure Disorders Drug Market Insights Forecast to 2030

Global Neurometabolic Disorders Market Insights Forecast to 2030

Global Circadian Rhythm Sleep Treatment Market Research Report 2025

Global Jet Lag Therapy Pharmaceuticals Market Insights Forecast to 2030

Global Tardive Dyskinesia TD Treatment Drugs Market Insights Forecast to 2030

Global Narcolepsy Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions